Chronic Kidney Disease Is Common in Survivors of Pediatric Allogeneic Hematopoietic Cell Transplantation: A Pediatric Transplantation and Cellular Therapy Consortium Study

Christine Duncan(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Sangeeta Hingorani(University of Washington), Scott Baker(Environmental Molecular Sciences Laboratory), Mark T. Vander Lugt(University of Michigan–Ann Arbor), Michelle Hudspeth(Medical University of South Carolina), Jeffery James Auletta, Kimberly A. Kasow(University of North Carolina at Chapel Hill), Kristen Beebe(Phoenix Children's Hospital), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), Eneida R. Nemecek(Oregon Health & Science University), Jeffrey S. Huo, Muna Qayed(Emory University), Emmanuel Katsanis(University of Arizona), W Scott Goebel, Benjamin Oshrine(Johns Hopkins All Children's Hospital), Wendy B. London(Dana-Farber Cancer Institute), Rabi Hanna(Cleveland Clinic), Roger Giller(Center for Cancer and Blood Disorders), Blachy J. Dávila Saldaña(Children's National), Pei‐Chi Kao(Boston Children's Hospital), James A. Connelly(Michigan Center for Translational Pathology), Hesham Eissa, Sonali Chaudhury(Northwestern University), Paul Martin(Duke Medical Center), Nahal Lalefar(University of California, San Francisco), Lynnette Anderson, Nan Chen(Qilu Hospital of Shandong University), Neena Kapoor, Shalini Shenoy(Washington University in St. Louis), Barbara Bambach(Roswell Park Comprehensive Cancer Center), Christopher C. Dvorak(University of California, San Francisco), Michael A. Pulsipher(Primary Children's Hospital)
Transplantation and Cellular Therapy
March 1, 2022
Cited by 1


Related Papers